Press release
Mono Vaccines (Epstein - Barr virus) Market Comprehensive Analysis, Opportunities, Classifications, Applications & Expert Opinions Appraised By Global Players GlaxoSmithKline Plc., Henogen SA, and others.
Global Mono Vaccines (Epstein - Barr virus) Market
Epstein-Barr virus also known as human herpesvirus 4 is the causative agent of mono/ kissing disease. Epstein–Barr virus is the most common type of virus in humans and is one of eight known human herpes virus types in the herpes family. According to the data published by Fred Hutchinson Cancer Research Center in 2018, Epstein–Barr virus infects about 9 out of 10 people globally at some point in their lives
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2002
Mono Vaccines (Epstein - Barr virus) Market Drivers
Increasing research and development activities by various universities and companies for development of novel Mono Vaccines or Epstein - Barr virus vaccines is expected to fuel global mono vaccines (Epstein - Barr Virus) market growth in the near future. For instance, in April 2018, Researchers from Fred Hutchinson Cancer Research Center and the University of Washington developed a human antibody in laboratory tests that blocks infection by mono Epstein-Barr virus, or EBV.
Since 2017, University of Kansas School of Engineering and School of Pharmacy is studying genetics of human immune responses to produce a potent vaccine for Mono, Epstein - Barr virus, or EBV. Such increasing research activities by various organizations for development of novel vaccines for EBV will lead to the global mono vaccines (Epstein - Barr virus) market growth.
Furthermore, funding raised by various organizations to support the development of novel EBV vaccine is also expected to create a lucrative environment for mono vaccines (Epstein - Barr virus) market growth in the forecast period. For instance, in 2017, University of Kansas School of Engineering and School of Pharmacy received US$ 1.8 million, five-year grant form National Institutes of Health for conducting research to develop an effective vaccines for EBV.
High prevalence of Epstein - Barr virus is expected to increase demand for its vaccines and this is expected to drive the mono vaccines (Epstein - Barr virus) market growth in the near future. For instance, according to data published by National Center for Biotechnology Information in 2015, Epstein–Barr virus is the most common type of virus and globally, over 95% of adults are infected with EBV. According to the same source, it was estimated that in Africa around 50% of the children are infected before 1 year of age.
Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2002
Mono Vaccines (Epstein - Barr virus) Market Regional Analysis
North America is expected to hold a dominant position in global mono vaccines (Epstein - Barr virus) market over the forecast period. This is owing to increasing research and development activities by various organizations present in the region. For instance, in 2015, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, with other partners developed a nanoparticle-based vaccine against EBV. This novel vaccine can produce powerful neutralizing antibodies in vaccinated mice and non-human primates.
Asia Pacific mono vaccines (Epstein - Barr virus) market is expected to exhibit a good growth in the near future, owing to increasing prevalence of Epstein - Barr virus in the region. For instance, according to data published by Fred Hutchinson Cancer Research Center, in 2018, Epstein - Barr virus is one of the most common virus and caused most cancer cases and cancer deaths in southern China and Southeast Asia. It caused around 10% of gastric cancers and about 100% of nasopharyngeal carcinomas in the region.
Mono Vaccines (Epstein - Barr virus) Market Key Players
Key players operating in global Mono Vaccines (Epstein - Barr virus) market include, GlaxoSmithKline Plc., Henogen SA, and others.
Mono Vaccines (Epstein - Barr virus) Market Taxonomy:
The global mono vaccines (Epstein - Barr virus) market is segmented on the basis of age group, and region
By Age Group-
Adult
Pediatrics
By Region-
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/mono-vaccines-epstein-barr-virus-market-2002
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mono Vaccines (Epstein - Barr virus) Market Comprehensive Analysis, Opportunities, Classifications, Applications & Expert Opinions Appraised By Global Players GlaxoSmithKline Plc., Henogen SA, and others. here
News-ID: 1708285 • Views: …
More Releases from Coherent Market Insights
Future Scope of Medical Coding Market Is Booming Worldwide 2025-2032 | Oracle Co …
Medical Coding Market is estimated to be valued at USD 23.78 Bn in 2025 and is expected to reach USD 45.79 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.
The research report on the Medical Coding Market provides an in-depth analysis of the industry's current state and projected growth from 2025 to 2032. It presents key statistics, trends, and market dynamics that not…
Future Outlook of Nuclear Power Market Growth Driven by Rising Demand for Clean …
The global nuclear power market is estimated to be valued at USD 36.72 Bn in 2025 and is expected to reach USD 48.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.
The research report on the Nuclear Power Market provides an in-depth analysis of the industry's current state and projected growth from 2025 to 2032. It presents key statistics, trends, and market…
Mexico In-Vitro Diagnostics Market Set To Explode Opportunities, Future Scope 20 …
The Mexico in-vitro diagnostics market was valued at US$ 909.4 Mn in 2021 and is forecast to reach a value of US$ 1,540.1 Mn by 2028 at a CAGR of 7.8% between 2022 and 2028.
The research report on the Mexico In-Vitro Diagnostics Market provides an in-depth analysis of the industry's current state and projected growth from 2025 to 2032. It presents key statistics, trends, and market dynamics that not only…
Europe Iv Hydration Therapy Market Trends, Investment Opportunities, and Growth …
The Europe IV hydration therapy market is estimated to be valued at US$ 244.1 million in 2022 and is expected to exhibit a CAGR of 7.2% during the forecast period (2022-2030).
The research report on the Europe Iv Hydration Therapy Market provides an in-depth analysis of the industry's current state and projected growth from 2025 to 2032. It presents key statistics, trends, and market dynamics that not only clarify the existing…
More Releases for Epstein
Epstein-Barr Is Riskier Than You May Imagine
Introduction
The Epstein-Barr virus (EBV), a member of the herpesvirus family, is one of the most common human viruses, infecting nearly 90-95 % of the global population at some point in their lives. EBV is the primary cause of infectious mononucleosis ("mono") and is linked to several serious conditions, including Hodgkin's lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma, and multiple sclerosis (MS).
Despite its widespread prevalence and serious long-term health associations, no approved vaccines…
Epstein-Barr Virus (EBV) Market Growth, Applications, Innovations and Business O …
Introduction
The Epstein-Barr Virus (EBV), a member of the herpesvirus family, is one of the most common human viruses. It infects over 90% of the global population, often during childhood or adolescence, and remains dormant in the body for life. EBV is best known as the cause of infectious mononucleosis ("mono"), but it has also been linked to more serious conditions, including Hodgkin's lymphoma, Burkitt's lymphoma, gastric cancer, nasopharyngeal carcinoma, and…
Monovaccine (Epstein - Barr virus) Market 2024: In-Depth Analysis, Growth Driver …
The Latest study titled Monovaccine (Epstein - Barr virus) Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints.…
Epstein - Barr virus diagnosis and Treatment Market is Dazzling Worldwide and Fo …
The global Epstein - Barr virus diagnosis and treatment market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period (2023-2030). Epstein - Barr virus (EBV) is a type of the herpes virus, also known as human herpesvirus . It is a highly common human virus that spreads through body fluids, primarily saliva. Moreover, it can also spread through blood transfusions, and organ transplantations among other causes. This…
Epstein-Barr Virus Market Size is expected to grow by 2032, estimates DelveInsig …
DelveInsight's "Epstein-Barr Virus Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Epstein-Barr Virus, historical and forecasted epidemiology as well as the Epstein-Barr Virus market trends in the United States.
Key Takeaways from the Epstein-Barr Virus Market Report
• The increase in Epstein-Barr Virus Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per…
Mono Vaccines (Epstein-Barr virus) Market: Future Growth Prospects To 2030
Prophecy Market Insights has recently published the Mono Vaccines (Epstein-Barr virus) informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Mono Vaccines (Epstein-Barr virus) market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry.…
